%0 Journal Article
%T Is there still room for anti-angiogenic agents in small cell lung cancer?
%A Brighenti, Matteo
%A Tiseo, Marcello
%J Translational Cancer Research
%D 2018
%B 2018
%9 
%! Is there still room for anti-angiogenic agents in small cell lung cancer?
%K 
%X We thank the authors of the editorials (1-4) in  Transl Cancer Res  for their comments on the GOIRC-AIFA FARM6PMFJM trial (5). This is the first randomized prospective phase III study assessing the role of adding bevacizumab to standard platinum-etoposide chemotherapy on survival outcome in the first-line treatment of extensive stage (ES) small cell lung cancer (SCLC).
%U https://tcr.amegroups.org/article/view/20235
%P S528-S529
%@ 2219-6803